1. Zhu, Chu-Xu, Yan, Kai, Chen, Liang, Gao, Ping, Lian, Zhe-Xiong. 2024. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma. In Journal of hepatology, 81, 690-703. doi:10.1016/j.jhep.2024.05.007. https://pubmed.ncbi.nlm.nih.gov/38759889/
2. Cai, Weijuan, Chong, Kunying, Huang, Yunfei, Huang, Chun, Yin, Liang. 2023. Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress. In Redox biology, 69, 103010. doi:10.1016/j.redox.2023.103010. https://pubmed.ncbi.nlm.nih.gov/38160540/
3. Zhang, Song, Xie, Caifeng. 2017. The role of OXCT1 in the pathogenesis of cancer as a rate-limiting enzyme of ketone body metabolism. In Life sciences, 183, 110-115. doi:10.1016/j.lfs.2017.07.003. https://pubmed.ncbi.nlm.nih.gov/28684065/